Useful Documents

Membership

Learn about PSGBI membership

Pancreatitis Guidelines

For healthcare professionals, patients and carers

Grants and Bursaries

Funding for Member projects

Priority Setting Partnership

Pancreatitis Priority Setting Partnership (PSP)

Access the Journal

Free access for members

Pancreatology Journal, latest articles

Clinical predictors of <em>KRAS</em> mutation detection in liquid biopsies for pancreatic ductal adenocarcinoma

18 Jun 2025, 1 p.m.

Publication date: Available online 17 June 2025Source: PancreatologyAuthor(s): Takaaki Furukawa, ...

Clinicopathological features for clinically resectable peripherally located pancreatic ductal adenocarcinoma

18 Jun 2025, 1 p.m.

Publication date: Available online 17 June 2025Source: PancreatologyAuthor(s): Yoshinori Ohno, ...

Long-Term Survival and Quality of Life Improvement in Patients with Large Unresectable Malignant Main-Duct IPMN Treated with EUS-Guided RFA (with video)

18 Jun 2025, 1 p.m.

Publication date: Available online 18 June 2025Source: PancreatologyAuthor(s): Pradermchai Kongkam, ...

Pediatric Pancreas Segmentation from MRI Scans with Deep Learning

17 Jun 2025, 5 p.m.

Publication date: Available online 16 June 2025Source: PancreatologyAuthor(s): Elif Keles, ...

Uric Acid and Related Disorders in the Risk of Pancreatic Diseases: A UK Biobank Prospective Study

17 Jun 2025, 5 p.m.

Publication date: Available online 17 June 2025Source: PancreatologyAuthor(s): Yingluo Wang, ...

A Mendelian Randomization Study Investigating the Causal Effect of Simvastatin Consumption on Pancreatitis Risk.

15 Jun 2025, noon

Publication date: Available online 14 June 2025Source: PancreatologyAuthor(s): Wenfeng Lin, ...

Letter to Editor: Strengths and Methodological Considerations for Predicting Post-Pancreatectomy Acute Pancreatitis

14 Jun 2025, 3 p.m.

Publication date: Available online 14 June 2025Source: PancreatologyAuthor(s): Zhen Pengkai, ...

A real-world analysis of second-line treatment option, Gemcitabine plus Anlotinib and anti-PD1, in advanced pancreatic cancer: A critical insight

13 Jun 2025, noon

Publication date: Available online 12 June 2025Source: PancreatologyAuthor(s): Asjad Zahra, ...

(PERT) shortage

Position Statement: Pancreatic enzyme replacement therapy

ASM 2025 Birmingham,

UKIEUS&PSGBI Save the date Nov 26th to 28th Info coming soon

zzzCONTACT Study

Membership

Pancreatitis Guidelines

Grants and Bursaries

Priority Setting Partnership

Access the Journal

Pancreatology Journal, latest articles

Clinical predictors of <em>KRAS</em> mutation detection in liquid biopsies for pancreatic ductal adenocarcinoma

Clinicopathological features for clinically resectable peripherally located pancreatic ductal adenocarcinoma

Long-Term Survival and Quality of Life Improvement in Patients with Large Unresectable Malignant Main-Duct IPMN Treated with EUS-Guided RFA (with video)

Pediatric Pancreas Segmentation from MRI Scans with Deep Learning

Uric Acid and Related Disorders in the Risk of Pancreatic Diseases: A UK Biobank Prospective Study

A Mendelian Randomization Study Investigating the Causal Effect of Simvastatin Consumption on Pancreatitis Risk.

Letter to Editor: Strengths and Methodological Considerations for Predicting Post-Pancreatectomy Acute Pancreatitis

A real-world analysis of second-line treatment option, Gemcitabine plus Anlotinib and anti-PD1, in advanced pancreatic cancer: A critical insight

(PERT) shortage

ASM 2025 Birmingham,

Paper CRFs

Protocol

REDCap User Guide

CONTACT Study PowerPoint for Local Presentation

CONTACT Study Visual Abstract (Study Overview)

Local Patient Database Spreadsheet

FAQs

Collaborative Authorship Model